UBS Group’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.86M | Sell |
428,778
-309,968
| -42% | -$4.96M | ﹤0.01% | 2778 |
|
|
2025
Q1 | $14.4M | Buy |
738,746
+244,570
| +49% | +$4.75M | ﹤0.01% | 2053 |
|
|
2024
Q4 | $10.9M | Buy |
494,176
+128,956
| +35% | +$2.84M | ﹤0.01% | 2255 |
|
|
2024
Q3 | $6.15M | Buy |
365,220
+9,903
| +3% | +$167K | ﹤0.01% | 2092 |
|
|
2024
Q2 | $4.25M | Buy |
355,317
+145,144
| +69% | +$1.73M | ﹤0.01% | 2259 |
|
|
2024
Q1 | $2.33M | Buy |
210,173
+121,945
| +138% | +$1.35M | ﹤0.01% | 2843 |
|
|
2023
Q4 | $764K | Buy |
88,228
+50,401
| +133% | +$436K | ﹤0.01% | 3641 |
|
|
2023
Q3 | $289K | Buy |
37,827
+31,595
| +507% | +$242K | ﹤0.01% | 3997 |
|
|
2023
Q2 | $44.9K | Buy |
6,232
+1,929
| +45% | +$13.9K | ﹤0.01% | 5470 |
|
|
2023
Q1 | $26.2K | Buy |
+4,303
| New | +$26.2K | ﹤0.01% | 5794 |
|
|
2022
Q1 | – | Sell |
-2,865
| Closed | -$23K | – | 9200 |
|
|
2021
Q4 | $23K | Sell |
2,865
-1,885
| -40% | -$15.1K | ﹤0.01% | 6556 |
|
|
2021
Q3 | $44K | Buy |
+4,750
| New | +$44K | ﹤0.01% | 5331 |
|